|
|
|
 |
|
|
| |
|
|
|
|
 |
 |
| |
|
|
Reaching the Hardest to Reach -- Treating the Hardest to Treat: Summary of the Primary Outcomes of the North American Opiate Medication Initiative (NAOMI)
The NAOMI project compared the effectiveness of methadone with that of medical-grade heroin in treating long-term injection drug users. As with similar studies conducted in Europe, this report demonstrates that participants committed fewer crimes and experienced improved mental and physical health. NAOMI cost roughly $7,500 annually for each participant -- as opposed to the $50,000 required to pay for the associated criminal justice and health care costs of not providing treatment.
[More]
|
 |
 |
|
|
Drugs of the World
Kent University scholar Axel Klein presents new material from the Caribbean, West Africa and the Caucasus to illustrate the bizarre consequences of an internationally devised drug-control program. Topics include the key roles drugs have played in society, culture, ritual, religion and possibly human evolution. Drugs and the World restores the constructive aspect of drug use to the discussion.
[More]
|
 |
|
|
|
Evaluation of Proposition 36: The Substance Abuse and Crime Prevention Act of 2000: 2008 Report
As California voters recently debated Proposition 5, the most recent evaluation of Proposition 36 shows that alternatives to incarceration for simple drug possession are working well. Passed by voters in 2000, Proposition 36 diverted non-violent drug offenders to treatment programs instead of entering them into the criminal justice system. Since then the program has shown a cost-benefit ratio of approximately 4 to 1; in effect, those who completed the program saved the state of California $4 for every $1 allocated to the program.
[More]
|
 |
|
|
|
|
|
| |
|
|
Search our catalog, which includes electronic documents as well as records of our holdings at the Lindesmith Library in New York.
Title, Author, or Subject:
|
| |
|
 This report describes the activities and accomplishments of the Drug Policy Alliance and its partner organization, the Drug Policy Alliance Network, from June 1, 2007 through May 31, 2008.
[More]
|
| |
|
|
